Page 11 - IJB-4-1
P. 11

3D printing for drug manufacturing: A perspective on the future of pharmaceuticals

           drugs can be covalently or physically linked to the   area in its permanent shape but a compact, low surface
           hydrogel network to limit the drug’s release, whereas   area shape in its temporary shape; the drug would be
           this is impossible in FDM [74,75] . Drug release would only   ingested or implanted while in its compact shape, and
           occur as the bond between the drug and hydrogel, or the   once in the targeted location, external stimulus would
           hydrogel itself, degrades. It is important to note, though,   cause the transformation to its high surface area shape to
           that degradation of hydrogels often occurs primarily by   allow for high drug release rates.
           bulk degradation, as opposed to surface degradation,   Importantly, researchers have shown that the incor-
           due to high diffusion; surface erosion would be made   poration of drugs does not have a significant impact on
           possible by further modification and careful selection of   the thermo-mechanical behavior and shape memory
           the hydrogel materials [76–78] .                    properties of the SMPs [86,87] . Furthermore, SMPs exhibit-
                                                               ing biodegradability and zero-order drug release have
           3.4  Smart Materials for Drug Delivery              also been developed [79,88] . By leveraging the elas tic
           Drug delivery can greatly benefit from smart materials   properties of particular SMPs combined with hydro-
           which are compatible with 3D printing. More spe-    phobic materials, SMPs can be designed to release
           cifically, smart materials of interest include shape   drugs without an initial burst followed by hydrolytic
           memory materials and environment-stimulated materials   degradation. Another exemplary implementation of
                                                                                                    [89]
           such as pH- and temperature-sensitive materials. In   SMPs is for double layer delivery systems  . A multi-
           general terms, degradable shape memory polymer      layer approach allows for finer tuning of drug release,
           (SMP) are multifunctional materials which are designed   while still maintaining the mechanical properties of
           to conform to their therapeutically relevant shape and   an elastic material ideal for implantable applications.
           mechanical properties after implantation [79] . SMPs are   With a focus on drug eluting implants, SMP stents
           considered active polymers, as they change from a   have been designed to perform a double duty: provide
           temporary shape to their original, permanent shape upon   the mechanical function of an implantable stent while
           exposure to a stimulus. This controllable, conformable   simultaneously delivery drugs [90] . By adding the drug
           change can be leveraged for drug delivery. Most com-  eluting feature to SMPs, implants and stents can be
                                                                                                       [91]
           monly, the stimulus is in the form of a temperature   designed with anti-inflammatory agents built-in  .
           change, i.e. the internal temperature of the human body   4. Benefits of 3D printing for Drug Manu­
           compared to the outside temperature. pH-sensitive ma-  facturing
           terials are also very useful in designing SMPs: due to
           the dependence on the physiological environment of the   Once an appropriate 3D printing method is determined
           drug, pH sensitivity can act as a reversible switch for   and the material best suited for the pharmaceutical
           drug release as the drug form migrates through the body   application is selected, it is a matter of developing and
           or as the environment changes in acidity/alkalinity [80] .   printing the drug itself. It is at this stage in the drug
           Other possible stimuli include light, pressure, or a mag-  manufacturing process where 3D printing presents itself
                            [81]
           netic or electric field .                           as the ideal approach, attributed to some noteworthy
            When considering the printing of SMPs, it is often   benefits [92] . One of the primary considerations in the
           referred to as four-dimensional (4D) printing, wherein   delivery of drugs is the release characteristics. 3D
           the fourth dimension is time [82–85] . After 3D printing   printing enables increased geometric and architectural
           the drug form, the printed drug can change its shape or   complexity, facile fabrication of multi-layer delivery
           functionality when the external stimulus is applied. For   systems, and the application of various controlled
           instance, a drug form can be printed that has high surface   release mechanisms. Printing as an approach for drug
















           Figure 2. Theoretical scheme of 3D printing for drug manufacturing. Based on a patient’s specific prescription from his doctor, a custom
           medication is designed via computer-aided design. The dosage form may be composed of complex geometries, multiple doses, or even
           multiple drugs. Drug-loaded bioink (biocompatible material) is then 3D printed on-demand.

           6                           International Journal of Bioprinting (2018)–Volume 4, Issue 1
   6   7   8   9   10   11   12   13   14   15   16